On-site testing for drug abuse in urine;Bruk av hurtigtester for påvisning av rusmidler i urin

Tidsskrift for den Norske Laegeforening

Volumn 126, Issue 17, 2006, Pages 2257-2260

  Espnes, Ketil Arne ^a   Spigset, Olav ^a   Delaveris, Gerd Jorunn Møller ^b   Mørland, Jørg ^b   Smith Kielland, Anne ^b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b Nasjonalt Folkehelseinstitutt ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BENZODIAZEPIN 2 ONE DERIVATIVE; BUPRENORPHINE; CANNABIS; COCAINE; METHADONE; METHAMPHETAMINE; MORPHINE; OXAZEPAM; OXYCODONE; PHENCYCLIDINE;

ACCURACY; ARTICLE; DIAGNOSTIC PROCEDURE; DRUG ABUSE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; LABORATORY TEST; MEDICAL RESEARCH; RISK ASSESSMENT; SOCIAL ASPECT;

FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; NORWAY; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION; URINALYSIS;

EID: 33748756423     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cone EJ. New developments in biological measures of drug prevalence. I: National Institute of Drug Abuse Research Monographs 1997; 167: 108-30. http://www.nida.niv.gov/pdf/monographs/monograph167/download167.html (15.2.2006).
2. Unites States Department of Health and Human Services, Substanse Abuse & Mental Health Services Administration. Drug testing. http://dwp.samhsa. gov/DrugTesting/DTesting.aspx (15.2.2006).
3. Smith-Kielland A. Urinary excretion of 11-nor-9-carboxy-δ9 -tetrahydrocannabinol (δ9 -THC-COOH): a case with a long apparent terminal half-life. Scand J Clin Lab Invest 2006; 66: 169-72.
4. Grönholm M, Lillsunde P. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci Int 2001; 121: 37-46.
5. Leino A, Saarimies J, Grönholm M et al. Comparison of eight commercial on-site screening devices for drugs-of-abuse testing. Scand J Clin Lab Invest 2001; 61: 325-32.
6. Smith-Kielland A, Skuterud B, Mørland J. Urinary excretion of 11-nor-9-carboxy-δ9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users. J Anal Toxicol 1999; 23: 323-32.
7. Peace MR, Tarnai LD, Poklis A. Performance evaluation of four on-site-drug-testing devices for detection of drugs of abuse in urine. J Anal Toxicol 2000; 24: 589-94.
8. Sosial- og helsedirektoratet. Kvalitetsrutiner ved rusmiddeltesting av prøver i medisinsk sammenheng (behandling og diagnostikk). Rundskriv IS-13/2002. http://www.shdir.no/vp/multimedia/archive/00001/IS-13_2002_1151a.pdf (15.2.2006).
9. Sosial- og helsedirektoratet. Kvalitetskrav til rutiner for rusmiddeltesting hvor positivt analysesvar kan danne grunnlag for iverksetting av alvorlige sanksjoner. Rundskriv IS-14/2002. http://www.shdir.no/vp/ multimedia/archive/00001/IS-14_2002_1153a.pdf (15.2.2006).
10. Castberg I, Sandvik P. Prøvetaking ved rusmiddeltesting i urin. Tidsskr Nor Lægeforen 2005; 125: 293-4.
11. Vitus apotek. Pressemeldinger. Narko-hjemmetesten er her. http://www.vitusapotek.no/main.jhtml?navid=120&navtemplate=universal. jhtml&navxml=/repos/documents/0000/00/00/ 0b/2842.xml&language=no (15.2.2006).
12. Levy S, Van Hook S, Knight J. A review of internet-based home drug-testing products for parents. Pediatrics 2004; 113: 720-6.
13. Statens helsetilsyn. Forskrift om narkotika m.v. (narkotikalisten). http://home.powertech.no/belkjekk/dokum/forskrift.html (15.2.2006).